GECT-DZHK28: A First-in-Human Feasibility Study to Evaluate the Safety (and Short term Effectiveness) of the Autologous GrOwnValve Transcatheter Pulmonary Heart Valve
| Institution | Charité - Universitätsmedizin Berlin |
|---|---|
| Project leader | Boris Schmitt |
| Site | Berlin |
| Project type | Klinische Studie |
| Funding | € 417.987,72 |
| Begin | 01.09.2022 |
| End | 28.02.2031 |
Förderkennzeichen
81X1100229
Projektnummer
1614